OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance
Dario Gerace, Quan Zhou, Jennifer Hyoje-Ryu Kenty, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 1, pp. 100879-100879
Open Access | Times Cited: 40
Dario Gerace, Quan Zhou, Jennifer Hyoje-Ryu Kenty, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 1, pp. 100879-100879
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes
Nathaniel J. Hogrebe, Matthew Ishahak, Jeffrey R. Millman
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 530-548
Open Access | Times Cited: 77
Nathaniel J. Hogrebe, Matthew Ishahak, Jeffrey R. Millman
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 530-548
Open Access | Times Cited: 77
HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis
Li Luo, Jung‐Hyun Kim, Iliana Herrera, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 1
Li Luo, Jung‐Hyun Kim, Iliana Herrera, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 1
Current trends of clinical trials involving CRISPR/Cas systems
Song‐Yang Zhang, Yidi Wang, Dezhi Mao, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 19
Song‐Yang Zhang, Yidi Wang, Dezhi Mao, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 19
Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration
Mohamed A. Ghoneim, Mahmoud M. Gabr, Sawsan M. El-Halawani, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Mohamed A. Ghoneim, Mahmoud M. Gabr, Sawsan M. El-Halawani, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Identification of unique cell type responses in pancreatic islets to stress
Marlie M. Maestas, Matthew Ishahak, Punn Augsornworawat, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Marlie M. Maestas, Matthew Ishahak, Punn Augsornworawat, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead
Alessandro Grattoni, Gregory S. Korbutt, Alice A. Tomei, et al.
Nature Reviews Endocrinology (2024) Vol. 21, Iss. 1, pp. 14-30
Closed Access | Times Cited: 8
Alessandro Grattoni, Gregory S. Korbutt, Alice A. Tomei, et al.
Nature Reviews Endocrinology (2024) Vol. 21, Iss. 1, pp. 14-30
Closed Access | Times Cited: 8
Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers
Hannah A. Pizzato, Paula Alonso‐Guallart, James R. Woods, et al.
Stem Cell Reports (2024) Vol. 19, Iss. 2, pp. 299-313
Open Access | Times Cited: 7
Hannah A. Pizzato, Paula Alonso‐Guallart, James R. Woods, et al.
Stem Cell Reports (2024) Vol. 19, Iss. 2, pp. 299-313
Open Access | Times Cited: 7
Clinical translation of pluripotent stem cell-based therapies: successes and challenges
Josefine Rågård Christiansen, Agnete Kirkeby
Development (2024) Vol. 151, Iss. 7
Open Access | Times Cited: 7
Josefine Rågård Christiansen, Agnete Kirkeby
Development (2024) Vol. 151, Iss. 7
Open Access | Times Cited: 7
Genetically engineered hypoimmunogenic cell therapy
Akitsu Hotta, Sonja Schrepfer, András Nagy
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 960-979
Closed Access | Times Cited: 7
Akitsu Hotta, Sonja Schrepfer, András Nagy
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 960-979
Closed Access | Times Cited: 7
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
Xue Wang, Ziyuan Zeng, Dayan Li, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 1
Open Access
Xue Wang, Ziyuan Zeng, Dayan Li, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 1
Open Access
Bioengineered omental transplant site promotes pancreatic islet allografts survival in non-human primates
Hongping Deng, Alexander Zhang, Dillon Ren Rong Pang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 3, pp. 100959-100959
Open Access | Times Cited: 14
Hongping Deng, Alexander Zhang, Dillon Ren Rong Pang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 3, pp. 100959-100959
Open Access | Times Cited: 14
Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation
Beatrice Xuan Ho, Adrian Kee Keong Teo, Natasha Hui Jin Ng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Beatrice Xuan Ho, Adrian Kee Keong Teo, Natasha Hui Jin Ng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
From stem cells to pancreatic β-cells: strategies, applications, and potential treatments for diabetes
Xingrong Feng, Hongmei Zhang, Shanshan Yang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 3
Xingrong Feng, Hongmei Zhang, Shanshan Yang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 3
Hydrogel-Encapsulated Pancreatic Islet Cells as a Promising Strategy for Diabetic Cell Therapy
Zhikun Huan, Jingbo Li, Zhiqiang Luo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 3
Zhikun Huan, Jingbo Li, Zhiqiang Luo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 3
Encapsulated islet transplantation
Sophie S. Liu, Surim Shim, Yoshimasa Kudo, et al.
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 3
Sophie S. Liu, Surim Shim, Yoshimasa Kudo, et al.
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 3
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, Svetlana V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 9
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, Svetlana V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 9
Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
Rossana Caldara, Valentina Tomajer, Paolo Monti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Rossana Caldara, Valentina Tomajer, Paolo Monti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Revolutionizing pancreatic islet organoid transplants: Improving engraftment and exploring future frontiers
Noella Abraham, Tejaswini Kolipaka, Giriraj Pandey, et al.
Life Sciences (2024) Vol. 343, pp. 122545-122545
Closed Access | Times Cited: 2
Noella Abraham, Tejaswini Kolipaka, Giriraj Pandey, et al.
Life Sciences (2024) Vol. 343, pp. 122545-122545
Closed Access | Times Cited: 2
Advances in the Use of Biologics and Biomaterials toward the Improvement of Pancreatic Islet Graft Survival in Type 1 Diabetes
Michael Yilma Yitayew, М. А. Лугинина, Maryam Tabrizian
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 2
Michael Yilma Yitayew, М. А. Лугинина, Maryam Tabrizian
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 2
Challenges in Beta Cell Replacement for Type 1 Diabetes
Joana Lemos, Jay S. Skyler
Hormone Research in Paediatrics (2024), pp. 1-15
Closed Access | Times Cited: 1
Joana Lemos, Jay S. Skyler
Hormone Research in Paediatrics (2024), pp. 1-15
Closed Access | Times Cited: 1
Tryptophan metabolism promotes immune evasion in human pancreatic β cells
Latif Rachdi, Zhicheng Zhou, Claire Berthault, et al.
EBioMedicine (2023) Vol. 95, pp. 104740-104740
Open Access | Times Cited: 5
Latif Rachdi, Zhicheng Zhou, Claire Berthault, et al.
EBioMedicine (2023) Vol. 95, pp. 104740-104740
Open Access | Times Cited: 5
Therapeutic approaches of cell therapy based on stem cells and terminally differentiated cells: Potential and effectiveness
Ali Pirsadeghi, Negar Namakkoobi, Mahtab Sharifzadeh Behzadi, et al.
Cells and Development (2024) Vol. 177, pp. 203904-203904
Closed Access | Times Cited: 1
Ali Pirsadeghi, Negar Namakkoobi, Mahtab Sharifzadeh Behzadi, et al.
Cells and Development (2024) Vol. 177, pp. 203904-203904
Closed Access | Times Cited: 1
The Future of Beta Cells Replacement in the Era of Regenerative Medicine and Organ Bioengineering
Ekaterine Berishvili, Andrea Peloso, Alice A. Tomei, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 1
Ekaterine Berishvili, Andrea Peloso, Alice A. Tomei, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 1
Stem cell-derived islet therapy: is this the end of the beginning?
Veronica A. Cochrane, Matthias Hebrok
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 12, pp. 681-682
Closed Access | Times Cited: 4
Veronica A. Cochrane, Matthias Hebrok
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 12, pp. 681-682
Closed Access | Times Cited: 4
Challenges and opportunities in the islet transplantation microenvironment: a comprehensive summary of inflammatory cytokine, immune cells, and vascular endothelial cells
Qidong Chen, Long Liu, Xiaohong Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Qidong Chen, Long Liu, Xiaohong Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3